Better Health for Everyone

Diane was Deputy Chief Scientist at the Royal Pharmaceutical Society 2023-2025. She is also Honorary Chair and Professor of Pharmaceutical Public Health at the University of Nottingham.  Diane’s career spans national and international initiatives, including chairing the English Surveillance Programme for Antimicrobial Utilisation and Resistance and leading the global Antibiotic Guardian campaign. She has authored over 100 peer-reviewed publications and delivered keynote presentations worldwide.   

Diane’s recent research has focused on disparities in sepsis outcomes, examining how socioeconomic status, ethnicity, and geography influence diagnosis and mortality. Using data from over 23 million patient records, her studies reveal significant gaps in sepsis recognition and treatment among deprived populations, highlighting the urgent need for equitable healthcare access.  In 2024 she was awarded a 4 year NIHR Senior Clinical and Practitioner Award focused on tackling health inequalities in resistant bloodstream infections. 

Gina is a recipient of a number of prestigious awards including a National Primary Care Research Fellowship which supported her PhD. Gina was the first health visitor to receive this award. She has held visiting professorships at Karolinska Institute, Sweden, the University of Pennsylvania, University of California Davis, Seattle University, US and the University of Sao Paolo, Federal University, Brazil and was formerly a Canada Research Chair at the University of Alberta, Canada and Fellow of the American Academy of Nursing. She is a member of the academic advisory group for the NHS Race and Health Observatory and member of the maternity action group.   

In 2015, Gina was appointed as the Mary Seacole Professor of Ethnicity and Community Health at the University of Nottingham – the first nurse of BME origin to hold a professorship in a Russell Group university in England – and is now Professor Emerita. In 1998 she was awarded an MBE for services to young people and health promotion.  

Gina’s research focuses on ethnic minority populations and immigrant health, including social exclusion and equity in healthcare and ethno-cultural diversity in care giving. A further major theme in her research portfolio is international migration and maternity. This includes parenting issues, early parenthood and postnatal depression in different ethnic minority groups, and experiences of diverse ethnocultural groups during access to maternal healthcare services. Her most recent research contributions focused on the Apgar score and other neonatal tests for infants with darker skins, challenging current practice and highlighting the need for more inclusive neonatal assessments. 

Sube is an old age psychiatrist and an applied health researcher. He trained in medicine at St Thomas’s Hospital Medical School, in epidemiology at the London School of Hygiene and Tropical Medicine, and in psychiatry at Guy’s and the Maudsley hospitals and the Institute of Psychiatry, King’s College London. He has an MBA from the London Business School.    

Sube’s research focusses on improving quality of life and quality of care for those with dementia and the evaluation of new treatments and services. He also works nationally and internationally on strategy and policy development to improve care for people with dementia and older adults with complex needs. He served as the Department of Health’s senior professional advisor on dementia leading the development of the National Dementia Strategy for England. Subsequently he worked with the World Health Organisation promoting dementia as a global priority in its Global Action Plan. He has championed under-served groups with research into barriers to care for people from minority ethnic groups and leads DETERMIND, the world’s largest research programme into inequalities and inequities in dementia outcomes and care.  

 Nigel was awarded his PhD from the University of Cambridge. He completed his postdoctoral training at the University of Cambridge and at Weill Cornell Medicine, where he became a faculty member in 2004. He joined the University of Nottingham in 2010, where he now leads a team of cancer experts who are working to tackle the challenge of cancer inequities.   

 As part of the SAMBAI project, the University of Nottingham’s Centre for Cancer Sciences is striving to decode the factors that cause and influence disparate cancer outcomes in underserved populations of African descent. Through the involvement of early career researchers, the Nottingham Prostate Cancer Support Group and Nottingham Breast Cancer Research Centre, the University of Nottingham is training the next generation of patient-focussed translational researchers to serve all our communities to address cancer inequities.